Avalyn Pharma Inc. (AVLN)
NASDAQ: AVLN · Real-Time Price · USD
29.76
-0.52 (-1.72%)
Nov 16, 2026, 4:00 PM EST - Market closed
Avalyn Pharma Employees
Avalyn Pharma had 55 employees as of June 30, 2026. The number of employees increased by 5 or 10.00% since the number was reported on December 31, 2025. That makes Avalyn Pharma the 34,584th largest employer in the world and 4,586th in the United States.
Employees
55
Change
5
Growth
10.00%
Revenue / Employee
n/a
Profits / Employee
-$1,988,818
Market Cap
1.32B
Employees Chart
| Date | Employees | Change | Growth |
|---|---|---|---|
| Jun 30, 2026 | 55 | 5 | 10.00% |
| Dec 31, 2025 | 50 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Novavax | 749 |
| Ocular Therapeutix | 325 |
| UroGen Pharma | 300 |
| Structure Therapeutics | 281 |
| Innoviva | 159 |
| Absci | 140 |
| AnaptysBio | 104 |
| Taysha Gene Therapies | 99 |
AVLN News
- 15 hours ago - Avalyn Pharma price target lowered to $53 from $57 at Morgan Stanley - TheFly
- 4 days ago - Avalyn Pharma Earnings release: Q3 2026 - Filings
- 4 days ago - Avalyn Pharma Quarterly report: Q3 2026 - Filings
- 5 days ago - Avalyn Pharma Slides: Corporate presentation - Filings
- 6 days ago - Avalyn Pharma Transcript: 3rd Annual Guggenheim Healthcare Innovation Conference - Transcripts
- 13 days ago - Avalyn to Present at Upcoming Investor Conferences - GlobeNewsWire
- 6 weeks ago - Avalyn Pharma initiated with an Outperform at Raymond James - TheFly
- 1 month ago - Avalyn Pharma announces published results from Phase 1 trials of AP02 - TheFly